<![CDATA[Focal HIFU/Cryotherapy Show Durable 10-Year Control in Prostate Cancer]]>

Data ReadoutpositiveFocal HIFUFocal CryotherapyPositive

AI Analysis

Summary

A 10-year analysis of 3,477 patients demonstrated durable prostate cancer control and low cancer-specific mortality with focal HIFU or cryotherapy for nonmetastatic disease, supporting the durability of these focal treatment approaches.

Clinical Trial Data

Primary Endpoint

Met

Patients

3,477

Outcome Details

10-year analysis of 3477 patients showed low prostate cancer-specific mortality with focal HIFU or cryotherapy for nonmetastatic disease, demonstrating durable control

Importance:6/10

Sentiment:

0.70

prostate cancerfocal therapyHIFUcryotherapylong-term dataoncology

Related Companies

$INTS

Read the original article

Published by Cancer Network on July 21, 2026 3:30 PM

Read Original